Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis
Acta Biochimica et Biophysica Sinica · 2023
DOI: 10.3724/abbs.2023052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2023. Verfasst von Min Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing 210004, China. Hauptthemen laut MEDLINE: Lung Neoplasms, MicroRNAs, Ovarian Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing 210004, China.
- Department of Gynecology, Gannan Medical University, Ganzhou 341000, China.
- Jiangsu Institute of Cancer Research, the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Zitieren
APA
Zhang, M., Sun, Y., Xu, H., Shi, Y., Shen, R., Teng, F., Xu, J., & Jia, X. (2023). Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2023052
Vancouver
Zhang M, Sun Y, Xu H, Shi Y, Shen R, Teng F, et al. Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis. Acta Biochimica et Biophysica Sinica. 2023. doi:10.3724/abbs.2023052
BibTeX
@article{Zhang2023,
author = {Zhang, Min and Sun, Yu and Xu, Hanzi and Shi, Yaqian and Shen, Rong and Teng, Fang and Xu, Juan and Jia, Xuemei},
title = {Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2023},
doi = {10.3724/abbs.2023052}
}
EUVIMED